Flupirtine: Clinical pharmacology
- PMID: 22557738
- PMCID: PMC3339720
- DOI: 10.4103/0970-9185.94833
Flupirtine: Clinical pharmacology
Abstract
Flupirtine is neither an opioid nor a non steroidal anti-inflammatory drug (NSAID) producing its analgesic action through blockade of glutamate N-methyl-D-aspartate receptor. It is devoid of adverse effects of routinely used analgesic drugs, but is equally efficacious in reducing pain sensation. It has a distinctive mechanism of action, exerting a dual therapeutic effect with both analgesic and muscle relaxant properties that has utility in the treatment of pain, including that associated with muscle tension.
Keywords: Flupirtine; N-methyl-D-aspartate receptor; non-steroidal anti-inflammatory drug; opioids.
Conflict of interest statement
References
-
- Devulder J. Flupirtine in Pain Management Pharmacological Properties and Clinical Use. CNS Drugs. 2010;24:867–81. - PubMed
-
- Schuster G, Schwarz M, Block F, Pergande G, Schmidt WJ. Flupirtine: A review of its neuroprotective and behavioral properties. CNS Drug Rev. 1998;4:149–64.
-
- Kornhuber J, Maler M, Wiltfang J, Bleich S, Degner D, Rüther E. Neuronal potassium channel opening with flupirtine. Fortschr Neurol Psychiatr. 1999;67:466–75. - PubMed
-
- Rupalla K, Weihong C, Krieglstein J. Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration. Eur J Pharmacol. 1995;294:469–73. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
